Target WP5 - Ricapps

The network

research programme

02

WP 5. Diagnostic and therapeutic optimisation of prevalent diseases in primary care.

Coordinator

Alfonso Leiva

Research Group GRAPP-caIB

RD24/0005/0008

aleiva@ibsalut.es

Participating Groups

Cardiocat. IP:

Rafel Ramos (RD24/0005/0001)

BIPS. IP:

Alvaro Sanchez (RD24/0005/0017)

GRAP-caIB. IP:

Alfonso Leiva (RD24/0005/0008)

IMIM. IP:

Maria Sala (RD24/0005/0002)

Valencia. IP:

Isabel Hurtado (RD24/0005/0009)

Canary Islands. IP:

Lilisbeth Perestelo (RD24/0005/0003)

Galicia. IP:

Francisco Gude (RD24/0005/0010)

GRenSSAP. IP:

Anna Berenguera (RD24/0005/0005)

Sant Joan de Déu. IP:

Montserrat Gil (RD24/0005/0007)

Madrid. IP:

Isbael del Cura (RD24/0005/0015)

FAD. IP:

Carola Orrego (RD24/0005/0025)

Research lines

Line 1 Diagnosis and Decision-making in PHC: To develop, assess and implement validated and effective instruments, tools and devices to increase diagnosis accuracy in PHC including Telemedicine. We aim to promote excellence in one of the most important determinants of subsequent medical interventions (e.g., treatments, referrals) and to involve patients as an integral part of the diagnostic processes, enhancing a personalized and effective care.

Task 1. To assess test performance of biomarkers, technologies or instruments to enhance diagnostic performance and reasoning in PHC.

Line 2 Tackle medical overuse and misuse in PHC: To develop and implement successful, cost-effective interventions to foster the appropriate use of healthcare services and to reduce the negative impact of non-beneficial care. We aim to design and assess effective interventions for PHC professionals to decrease the negative impact of medical overuse, increase awareness among PHC professionals and patients about ineffective and low-value practices, and provide evidence-based solutions to reduce patient harm, inefficient use of healthcare resources, and wasteful spending in PHC.

Task 1. To plan, design and evaluate interventions for the deprescription and deimplementation of practices or treatments that do not engender a positive impact on patients’ health outcomes, to improve adequacy, patient safety and the appropriate use of PHC resources.

Task 2. To plan, design and to evaluate life-style interventions to reduce unnecessary therapeutic treatments.

Line 3 Quality and safety of patient care in PHC by addressing low-value practices, improving adherence to clinical practice guidelines, identifying and mitigating errors, and fostering a culture of patient safety. We aim to reduce the risk of errors and harm in PHC patients by identifying low value practices, promote adherence to clinical practice guidelines and patient safety in PHC centers and reduce prescriptions errors. Our focus includes medication management, diagnosis, care transitions and referrals. By targeting these areas, we seek to implement effective and sustainable changes that enhance patient safety and care quality in PHC.

Task 1. To update an inventory of low value practices in PHC.

Task 2. Adherence to Clinical Practice Guidelines in Primary Care: To evaluate and improve adherence to clinical practice guidelines in PHC, ensuring high-quality patient care and optimizing health outcomes.

Task 3. To identify errors and areas for improvement in PHC and to analyze real-world-data of drug exposures.

Task 4. To develop and evaluate multifactorial interventions to promote patient safety in PHC centers and reduce prescriptions errors.